Gladius Capital Management LP - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 179 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is 7.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gladius Capital Management LP ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$29,078
+26.8%
1,301
+21.9%
0.00%0.0%
Q2 2023$22,930
-22.6%
1,067
-13.6%
0.00%
-50.0%
Q1 2023$29,628
-25.4%
1,235
-27.9%
0.00%
-33.3%
Q4 2022$39,742
+16.9%
1,713
-17.3%
0.00%
+200.0%
Q3 2022$34,0002,0710.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q2 2023
NameSharesValueWeighting ↓
Rubric Capital Management LP 1,926,283$40,105,0003.74%
Camber Capital Management LP 4,000,000$83,280,0002.20%
FRAZIER MANAGEMENT LLC 943,666$19,647,0001.76%
MANGROVE PARTNERS IM, LLC 593,741$12,362,0001.56%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 303,685$6,323,0001.07%
Eventide Asset Management 2,427,976$50,550,0000.99%
Avidity Partners Management LP 1,000,400$20,828,0000.97%
RICE HALL JAMES & ASSOCIATES, LLC 1,108,219$23,073,0000.93%
Perceptive Advisors 2,058,068$42,849,0000.63%
Rock Springs Capital Management LP 1,175,000$24,464,0000.62%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders